Considerations To Know About Is ABBV-744 effective for hematologic cancers?
In Section C, contributors will get ABBV-744 and oral navitoclax. In Phase D, individuals will acquire ABBV-744 and ruxolitinib. Participants will obtain treatment until eventually disorder progression or even the contributors are unable to tolerate the study drugs.Ubiquitin-linked proteins that control The steadiness of important super enhancer-me